
India Amita Gupta, School of Medicine Robert Bollinger, Jr., School of Medicine Robert Gilman, Bloomberg School of Public Health
>> Dr. Jain's faculty page
Tuberculosis (TB) is the most common cause of morbidity/mortality in HIV-infected individuals in India, which has among the world's highest burden of HIV and TB. Since children acquire HIV/TB from their caregivers, active TB is highly prevalent (14-67.5%) among HIV-infected young children in India - a vulnerable population, where lack of early detection/prevention of TB often has fatal consequences. Diagnosis of TB is particularly challenging in young children. Due to similar clinical presentation, active TB cannot be reliably distinguished from HIV (or co-infections). Tuberculin skin test (TST) is unreliable and bacterial confirmation (culture), when available, does not provide a diagnosis for weeks to months. T¬SPOT.TB is more sensitive/specific than TST for the diagnosis of active TB especially in young children with high rates of HIV, malnutrition, BCG vaccination and non-tuberculous mycobacteria (NTB). Microscopic ¬observation drug-susceptibility (MODS) is a rapid assay for bacteriologic diagnosis of drug-susceptible and multi-drug resistant (MDR)-TB. Neither tests have been evaluated in the Indian setting, and the approach combining T-SPOT.TB and MODS, has never been tested previously. We will build on an existing Indo-US collaboration with Byramjee Jeejeebhoy Medical College (BJMC), and King Edward Memorial Hospital (KEM) in Pune, India. Inpatient/outpatient facilities at these centers serve children with high burden of HIVITB. In this study we will test the hypothesis that combined use of T-SPOT. TB and MODS will be non-inferior to current best standard of care for the diagnosis of active TB in young children in this region, but will have significantly reduced time to detection (including MDR- TB strains). >> See all 2007 Faculty Grant in Global Health winners >> See all 2007 Faculty Grant in Global Health winners
|